comparemela.com

Latest Breaking News On - American association for ophthalmology annual meeting - Page 1 : comparemela.com

Aflibercept 8 mg Late-breaking Data Presented at Retina Society in Diabetic Macular Edema and Wet Age-related Macular Degeneration

/PRNewswire/ Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced late-breaking presentations of updated results from two positive pivotal trials.

United statesMark hudsonMary heatherDavid brownPrnewswire regeneron pharmaceuticals incRegeneron pharmaceuticals incRegeneron genetics centerAmerican association for ophthalmology annual meetingTrial programExchange commissionRetina society in pasadenaResearch at retina consultants of texasRetina societyAnnual scientific sessionRetina consultantsAmerican association

Bayer : Detailed data from pivotal studies with aflibercept 8 mg demonstrate sustained improvements in visual acuity and anatomic measures with large majority of patients maintaining treatment intervals of 16

05 November 2022 | 06:59 AM Europe/Amsterdam . | November 5, 2022

United statesChristian rommelBayer agMember of the executive committee bayerHead of researchScientific meeting of the retina societyAmerican association for ophthalmology annual meetingRetina societyAnnual scientific meetingUniversity hospitalExecutive committeePharmaceutical divisionAmerican associationOphthalmology annualBayer ag stock exchangePress release

vimarsana © 2020. All Rights Reserved.